Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus

A woman with aggressive refractory systemic lupus erythematosus was treated with a short course of the bispecific antibody teclistamab (anti–B-cell maturation antigen and anti-CD3) and had a drug-free complete remission.

​   The New England Journal of Medicine: Search Results in Allergy/Immunology